Robert M Mitchell, Megan J Janssen, Irina Karavanova, Detlef Vullhorst, Katrina Furth, Anthony Makusky, Sanford P Markey, Andres Buonanno
ErbB4 signaling in the central nervous system is implicated in neuropsychiatric disorders and epilepsy. In cortical tissue, ErbB4 associates with excitatory synapses located on inhibitory interneurons. However, biochemical and histological data described herein demonstrate that the vast majority of ErbB4 is extrasynaptic and detergent-soluble. To explore the function of this receptor population, we used unbiased proteomics, in combination with electrophysiological, biochemical, and cell biological techniques, to identify a clinically relevant ErbB4-interacting protein, the GABAA receptor α1 subunit (GABAR α1). We show that ErbB4 and GABAR α1 are robustly coexpressed in hippocampal interneurons, and that ErbB4-null mice have diminished cortical GABAR α1 expression. Moreover, we characterize a Neuregulin-mediated ErbB4 signaling modality, independent of receptor tyrosine kinase activity, that couples ErbB4 to decreased postsynaptic GABAR currents on inhibitory interneurons. Consistent with an evolving understanding of GABAR trafficking, this pathway requires both clathrin-mediated endocytosis and protein kinase C to reduce GABAR inhibitory currents, surface GABAR α1 expression, and colocalization with the inhibitory postsynaptic protein gephyrin. Our results reveal a function of ErbB4, independent of its tyrosine kinase activity, that modulates postsynaptic inhibitory control of hippocampal interneurons and may provide a novel pharmacological target in the treatment of neuropsychiatric disorders and epilepsy.
Nature. 1995 Nov 23;378(6555):390-4
[PMID:
7477376]
Arch Gen Psychiatry. 2009 Sep;66(9):938-46
[PMID:
19736350]
J Neurosci. 2011 Mar 2;31(9):3225-33
[PMID:
21368034]
Mol Psychiatry. 2008 Feb;13(2):147-61
[PMID:
17471287]
Neurosci Lett. 2003 Sep 25;349(1):9-12
[PMID:
12946574]
J Neurosci. 2005 Oct 12;25(41):9378-83
[PMID:
16221846]
Neuropsychopharmacology. 2011 Sep;36(10):2103-10
[PMID:
21677653]
Nature. 2010 Apr 1;464(7289):763-7
[PMID:
20360742]
J Neurosci. 2005 May 18;25(20):4974-84
[PMID:
15901778]
Nat Rev Neurosci. 2008 Jun;9(6):437-52
[PMID:
18478032]
Neuron. 2000 May;26(2):443-55
[PMID:
10839362]
Mol Psychiatry. 2005 Dec;10(12):1074-88, 1057
[PMID:
16172613]
Science. 2001 Dec 7;294(5549):2179-81
[PMID:
11679632]
J Neurosci. 1997 May 1;17(9):2959-66
[PMID:
9096132]
EMBO J. 2006 Sep 20;25(18):4381-9
[PMID:
16946701]
Nature. 1997 Aug 14;388(6643):686-90
[PMID:
9262404]
J Neurosci. 2012 Oct 3;32(40):13889-95
[PMID:
23035098]
Cell Commun Signal. 2011 Oct 28;9(1):23
[PMID:
22035226]
J Neurosci. 2000 Mar 15;20(6):2202-8
[PMID:
10704495]
Brain Res Bull. 2007 Jul 12;73(4-6):210-9
[PMID:
17562386]
J Neurosci. 2009 Sep 30;29(39):12255-64
[PMID:
19793984]
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3596-601
[PMID:
10725395]
J Neurosci. 2012 Feb 29;32(9):2988-97
[PMID:
22378872]
J Biol Chem. 1999 Dec 17;274(51):36565-72
[PMID:
10593956]
Schizophr Res. 2011 Sep;131(1-3):165-73
[PMID:
21745723]
Cereb Cortex. 2009 Mar;19(3):612-8
[PMID:
18632742]
J Neurosci. 2002 Apr 1;22(7):2513-21
[PMID:
11923416]
Biol Psychiatry. 2011 Oct 1;70(7):636-45
[PMID:
21664604]
J Neurosci. 2005 Nov 9;25(45):10469-78
[PMID:
16280585]
J Neurosci. 2006 Nov 1;26(44):11295-303
[PMID:
17079657]
Cancer Cell. 2008 May;13(5):385-93
[PMID:
18455122]
Neuropharmacology. 2009 Oct-Nov;57(5-6):481-95
[PMID:
19631671]
Eur J Neurosci. 1994 May 1;6(5):837-53
[PMID:
8075825]
Neuron. 2012 Sep 20;75(6):951-62
[PMID:
22998865]
Nature. 1997 May 29;387(6632):512-6
[PMID:
9168115]
Nat Neurosci. 2011 Dec 11;15(2):267-73
[PMID:
22158511]
Nat Neurosci. 2011 Dec 11;15(2):258-66
[PMID:
22158510]
Curr Opin Neurobiol. 2001 Jun;11(3):287-96
[PMID:
11399426]
Brain Res Rev. 2006 Aug;51(2):161-75
[PMID:
16412517]
Ann Neurol. 2006 Jun;59(6):983-7
[PMID:
16718694]
Psychopharmacology (Berl). 2004 Jun;174(1):151-62
[PMID:
15205886]
Physiol Rev. 2011 Jul;91(3):1009-22
[PMID:
21742794]
Nat Rev Neurosci. 2008 May;9(5):331-43
[PMID:
18382465]
Anal Chem. 1996 Mar 1;68(5):850-8
[PMID:
8779443]
Mol Psychiatry. 2004 Feb;9(2):213-8
[PMID:
14699422]
J Neurosci. 2012 Apr 25;32(17):5853-67
[PMID:
22539847]
J Comp Neurol. 2004 Apr 26;472(2):156-72
[PMID:
15048684]
Dev Cell. 2009 May;16(5):633-47
[PMID:
19460341]
Nature. 1987 Aug 27-Sep 2;328(6133):820-3
[PMID:
3498122]
J Cell Biol. 2003 Jun 23;161(6):1133-41
[PMID:
12821646]
Cell. 2006 Oct 6;127(1):185-97
[PMID:
17018285]
Epilepsia. 2012 Aug;53(8):e161-5
[PMID:
22812724]
Sci STKE. 2006 Oct 10;2006(356):re11
[PMID:
17033044]
Mol Pharmacol. 1995 Dec;48(6):1099-107
[PMID:
8848010]
J Biol Chem. 2001 Nov 23;276(47):44099-107
[PMID:
11495899]
Neuron. 2013 Apr 10;78(1):81-93
[PMID:
23583108]
Trends Neurosci. 2012 Jan;35(1):57-67
[PMID:
22154068]
J Neurosci. 2000 Nov 1;20(21):7972-7
[PMID:
11050117]
Nat Rev Neurosci. 2004 Feb;5(2):97-107
[PMID:
14735113]
J Neurophysiol. 2002 Dec;88(6):3208-17
[PMID:
12466441]
Neuron. 2011 May 12;70(3):385-409
[PMID:
21555068]
Nat Neurosci. 2005 Jul;8(7):889-97
[PMID:
15951809]
